{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:06:24Z","timestamp":1789009584534,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10032-6","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:47:09Z","timestamp":1780156029000},"page":"4743-4755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches"],"prefix":"10.1007","volume":"71","author":[{"given":"Pablo","family":"Mart\u00ednez-Blanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Gil-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Torralba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"10032_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u2013263.","journal-title":"CA Cancer J Clin."},{"key":"10032_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatol Baltim Md. 2021;73:4\u201313.","journal-title":"Hepatol Baltim Md."},{"key":"10032_CR3","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatol Baltim Md. 2023;78:1922\u20131965.","journal-title":"Hepatol Baltim Md."},{"key":"10032_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","volume":"72","author":"A Vitale","year":"2023","unstructured":"Vitale A, Svegliati-Baroni G, Ortolani A et al. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002\u20132033 the ITA LI. CA database. Gut 2023;72:141\u2013152.","journal-title":"Gut"},{"key":"10032_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal AG, Zhang E, Narasimman M et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;77:128\u2013139.","journal-title":"J Hepatol."},{"key":"10032_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76:681\u2013693.","journal-title":"J Hepatol."},{"key":"10032_CR7","doi-asserted-by":"publisher","first-page":"e0143","DOI":"10.1097\/HC9.0000000000000143","volume":"7","author":"K Seif El Dahan","year":"2023","unstructured":"Seif El Dahan K, Reczek A, Daher D et al. Multidisciplinary care for patients with HCC: a systematic review and meta-analysis. Hepatol Commun. 2023;7:e0143.","journal-title":"Hepatol Commun."},{"key":"10032_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Sharma R, Allara E et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66:338\u2013346.","journal-title":"J Hepatol."},{"key":"10032_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"B Sangro","year":"2025","unstructured":"Sangro B, Argemi J, Ronot M et al. EASL clinical practice guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82:315\u2013374.","journal-title":"J Hepatol."},{"key":"10032_CR10","first-page":"S09237534250007","volume":"29","author":"A Vogel","year":"2025","unstructured":"Vogel A, Chan SL, Dawson LA et al. Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;29:S0923753425000730.","journal-title":"Ann Oncol."},{"key":"10032_CR11","first-page":"193","volume-title":"TNM Classification of Malignant Tumours","author":"LH Sobin","year":"2011","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, USA: Wiley; 2011; 193."},{"key":"10032_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41591-024-03398-5","volume":"31","author":"SK Yoo","year":"2025","unstructured":"Yoo SK, Fitzgerald CW, Cho BA et al. Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data. Nat Med. 2025;31:869\u2013880.","journal-title":"Nat Med."},{"key":"10032_CR13","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","volume":"30","author":"E Vorontsov","year":"2024","unstructured":"Vorontsov E, Bozkurt A, Casson A, Shaikovski G, Zelechowski M, Severson K et al. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat Med. 2024;30:2924\u20132935.","journal-title":"Nat Med."},{"key":"10032_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91\u201396.","journal-title":"Gastroenterology."},{"key":"10032_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-051322-122539","volume":"75","author":"NR Mazumder","year":"2024","unstructured":"Mazumder NR, Fontana RJ. MELD 3.0 in advanced chronic liver disease. Annu Rev Med. 2024;75:233\u201345.","journal-title":"Annu Rev Med."},{"key":"10032_CR16","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/hep.30932","volume":"71","author":"SK Asrani","year":"2020","unstructured":"Asrani SK, Jennings LW, Kim W et al. MELD-GRAIL-Na: glomerular filtration rate and mortality on liver-transplant waiting list. Hepatology. 2020;71:1766\u201374.","journal-title":"Hepatology."},{"key":"10032_CR17","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1111\/ajt.15559","volume":"19","author":"EL Godfrey","year":"2019","unstructured":"Godfrey EL, Malik TH, Lai JC et al. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019;19:3299\u20133307.","journal-title":"Am J Transplant."},{"key":"10032_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.1129","volume":"155","author":"JE Locke","year":"2020","unstructured":"Locke JE, Shelton BA, Olthoff KM et al. Quantifying sex-based disparities in liver allocation. JAMA Surg. 2020;155:e201129.","journal-title":"JAMA Surg."},{"key":"10032_CR19","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","volume":"161","author":"WR Kim","year":"2021","unstructured":"Kim WR, Mannalithara A, Heimbach JK et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021;161:1887-1895.e4.","journal-title":"Gastroenterology."},{"key":"10032_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/00365521.2014.958094","volume":"50","author":"R Jeong","year":"2015","unstructured":"Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50:439\u2013446.","journal-title":"Scand J Gastroenterol."},{"key":"10032_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W Dunn","year":"2005","unstructured":"Dunn W, Jamil LH, Brown LS et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353\u2013358.","journal-title":"Hepatology."},{"key":"10032_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/j.gastro.2019.07.006","volume":"157","author":"M Ghabril","year":"2019","unstructured":"Ghabril M, Gu J, Yoder L et al. Development and validation of a model consisting of comorbidity burden to calculate risk of death within 6 months for patients with suspected drug-induced liver injury. Gastroenterology. 2019;157:1245\u20131252.","journal-title":"Gastroenterology."},{"key":"10032_CR23","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/s41467-024-45733-x","volume":"21","author":"R Yagi","year":"2024","unstructured":"Yagi R, Goto S, Himeno Y et al. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms. Nat Commun. 2024;21:2536.","journal-title":"Nat Commun."},{"key":"10032_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jenvman.2021.112015","volume":"15","author":"W Chen","year":"2021","unstructured":"Chen W, Lei X, Chakrabortty R. Evaluation of different boosting ensemble machine learning models and novel deep learning and boosting framework for head-cut gully erosion susceptibility. J Environ Manage. 2021;15:112015.","journal-title":"J Environ Manage."},{"key":"10032_CR25","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.3390\/diagnostics13182952","volume":"13","author":"M Su\u00e1rez","year":"2023","unstructured":"Su\u00e1rez M, Mart\u00ednez R, Torres AM. A machine learning-based method for detecting liver fibrosis. Diagnostics. 2023;13:2952.","journal-title":"Diagnostics."},{"key":"10032_CR26","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/sim.7993","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KIE, Ensor J et al. Minimum sample size for developing a multivariable prediction model: Part I - Continuous outcomes. Stat Med. 2019;38:1262\u20131275.","journal-title":"Stat Med."},{"key":"10032_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5604\/16652681.1198800","volume":"15","author":"N Toshikuni","year":"2016","unstructured":"Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol. 2016;15:314\u2013325.","journal-title":"Ann Hepatol."},{"key":"10032_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M et al. A Model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464.","journal-title":"Hepatology."},{"key":"10032_CR29","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.3390\/s24144678","volume":"24","author":"O Zapata-Cortes","year":"2024","unstructured":"Zapata-Cortes O, Arango-Serna MD, Zapata-Cortes JA, Restrepo-Carmona JA. Machine learning models and applications for early detection. Sensors. 2024;24:4678.","journal-title":"Sensors."},{"key":"10032_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.asoc.2022.109067","volume":"1","author":"J Dong","year":"2022","unstructured":"Dong J, Chen Y, Yao B, Zhang X, Zeng N. A neural network boosting regression model based on XGBoost. Appl Soft Comput. 2022;1:109067.","journal-title":"Appl Soft Comput."},{"key":"10032_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"7","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;7:g7594.","journal-title":"BMJ."},{"key":"10032_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jhep.2010.03.010","volume":"53","author":"V Santi","year":"2010","unstructured":"Santi V, Trevisani F, Gramenzi A et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol. 2010;53:291\u2013297.","journal-title":"J Hepatol."},{"key":"10032_CR33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","volume":"64","author":"G Papatheodoridis","year":"2016","unstructured":"Papatheodoridis G, Dalekos G, Sypsa V et al. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J Hepatol. 2016;64:800\u2013806.","journal-title":"J Hepatol."},{"key":"10032_CR34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/jcm12030949","volume":"12","author":"MC Guan","year":"2023","unstructured":"Guan MC, Zhang SY, Ding Q et al. The performance of GALAD score for diagnosing hepatocellular carcinoma in patients with chronic liver diseases: a systematic review and meta-analysis. J Clin Med. 2023;12:949.","journal-title":"J Clin Med."},{"key":"10032_CR35","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u20131606.","journal-title":"J Hepatol."},{"key":"10032_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100535","volume":"27","author":"A Ruf","year":"2022","unstructured":"Ruf A, Dirchwolf M, Freeman RB. From child-pugh to MELD score and beyond: taking a walk down memory lane. Ann Hepatol. 2022;27:100535.","journal-title":"Ann Hepatol."},{"key":"10032_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF01095898","volume":"21","author":"V Arroyo","year":"1976","unstructured":"Arroyo V, Rod\u00e9s J, Guti\u00e9rrez-Liz\u00e1rraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976;21:249\u2013256.","journal-title":"Am J Dig Dis."},{"key":"10032_CR38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/lt.20329","volume":"11","author":"AE Ruf","year":"2005","unstructured":"Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005;11:336\u2013343.","journal-title":"Liver Transpl."},{"key":"10032_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-0039-1688750","volume":"39","author":"SC Sacleux","year":"2019","unstructured":"Sacleux SC, Samuel D. A critical review of MELD as a reliable tool for transplant prioritization. Semin Liver Dis. 2019;39:403\u2013413.","journal-title":"Semin Liver Dis."},{"key":"10032_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jhep.2013.10.010","volume":"60","author":"A Vitale","year":"2014","unstructured":"Vitale A, Volk ML, De Feo TM et al. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol. 2014;60:290\u2013297.","journal-title":"J Hepatol."},{"key":"10032_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s11605-011-1537-3","volume":"15","author":"MC Yu","year":"2011","unstructured":"Yu MC, Chan KM, Lee CF et al. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg. 2011;15:1440\u20131449.","journal-title":"J Gastrointest Surg."},{"key":"10032_CR42","doi-asserted-by":"publisher","first-page":"146045822098420","DOI":"10.1177\/1460458220984205","volume":"27","author":"D Chicco","year":"2021","unstructured":"Chicco D, Oneto L. Computational intelligence identifies alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and hemoglobin levels as most predictive survival factors for hepatocellular carcinoma. Health Informatics J. 2021;27:1460458220984205.","journal-title":"Health Informatics J."},{"key":"10032_CR43","doi-asserted-by":"publisher","unstructured":"Steyerberg EW. (2019) Clinical prediction models: a practical approach to development, validation, and updating [Internet]. Cham: Springer. (Statistics for Biology and Health). Available from: https:\/\/doi.org\/10.1007\/978-3-030-16399-0","DOI":"10.1007\/978-3-030-16399-0"},{"key":"10032_CR44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/cancers16061114","volume":"16","author":"M Su\u00e1rez","year":"2024","unstructured":"Su\u00e1rez M, Gil-Rojas S, Mart\u00ednez-Blanco P et al. Machine learning-based assessment of survival and risk factors in non-alcoholic fatty liver disease-related hepatocellular carcinoma for optimized patient management. Cancers. 2024;16:1114.","journal-title":"Cancers."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10032-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10032-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:18:24Z","timestamp":1789006704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10032-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10032"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10032-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived due to the number of patients, the study design (retrospective), the absence of a medical prescription, and the number of deceased patients.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University Hospital of Guadalajara (Ref. CEIm: 2023.16. EO).","order":3,"name":"Ethics","label":"Institutional review board","group":{"name":"EthicsHeading","label":"Declarations"}}]}}